<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01407848</url>
  </required_header>
  <id_info>
    <org_study_id>Uni-Koeln-1488</org_study_id>
    <secondary_id>2011-003473-29</secondary_id>
    <nct_id>NCT01407848</nct_id>
  </id_info>
  <brief_title>Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea</brief_title>
  <official_title>Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and
      term neonates with Transient Tachypnoea.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and
      term neonates with transient Tachypnoea. Patients received nebulised Furosemide iv solution 1
      mg/kg or nebulised 0,9% saline (4x/d) under blind conditions in random order so long as need
      a CPAP-treatment but max. 3 days. 20 Patient will be treating.

      The benefit will be measured as reduction of dyspnea, respiratory rate, oxygen demand and
      time on CPAP.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of the Silverman-Score</measure>
    <time_frame>0-72 h or up to end of CPAP after start of the study</time_frame>
    <description>The primary endpoint of the study is the reduction of the Silverman score as an indicator of respiratory distress of the infant.
Silverman Score is the standard score to describe the degree of respiratory distress of neonate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen supplementation</measure>
    <time_frame>0-72 h or up to end of CPAP after start of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A need for secondary intubation and mechanical ventilation</measure>
    <time_frame>1-3 day of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body weight</measure>
    <time_frame>1-3 day of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP-time</measure>
    <time_frame>0-72 h or up to end of CPAP after start of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood electrolytes (Na+, K+, Ca++, HCO3-, Cl-)</measure>
    <time_frame>0-72 h after start of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood gas (pH, pCO2,pO2)</measure>
    <time_frame>0-72 h after start of the study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Transient Tachypnoea of the Newborn</condition>
  <arm_group>
    <arm_group_label>Furosemide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg/kg/Ed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline 0,9%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1ml/kg/Ed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Furosemide</intervention_name>
    <description>Patients received nebulised Furosemide iv solution 1 mg/kg (4x/d) for max.3 consecutive days.</description>
    <arm_group_label>Furosemide</arm_group_label>
    <other_name>inhaled furosemide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline 0,9%</intervention_name>
    <description>nebulised 0,9% saline 4x/d for max.3 days</description>
    <arm_group_label>Saline 0,9%</arm_group_label>
    <other_name>natrium chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Neonates with 35+0-39+0 GA on the first day of life with the clinical diagnosis of
             Transient Tachypnoea

          -  The need for CPAP &gt;6 h to obtain the oxygen saturation &gt;92%

          -  Written informed consent of parent/guardian

        Exclusion Criteria:

          -  Systemic infection

          -  Intubation and mechanical ventilation before Inclusion in the trail

          -  Malformation and any other several disease with disturb of respiratory

          -  Subjects participating in other clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernhard Roth, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Cologne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ChildrenÂ´s Hospital University of Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2011</study_first_submitted>
  <study_first_submitted_qc>August 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2011</study_first_posted>
  <last_update_submitted>September 22, 2015</last_update_submitted>
  <last_update_submitted_qc>September 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Patrizia Nitsch-Felsecker</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachypnea</mesh_term>
    <mesh_term>Transient Tachypnea of the Newborn</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Furosemide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

